Losartan(科素亚)和卡托普利治疗高血压病的对照研究

Comparison Study of Losartan and Captopril Treatment of Essential Hypertension

  • 摘要: 目的:评价科素亚同卡托普利治疗高血压病的疗效及其对血脂、肾功能及副作用的影响。方法:59 例原发性高血压患者给予Losartan(科素亚)剂量50~100m g/天,治疗六周,对照组56 例服用卡托普利,剂量25m g/次,每天2~3次。治疗前后所有参与者测血压和测定胆固醇、甘油三酯、肾功能。结果:监测血压显示Losartan 组降压与卡托普利对照组无差异,对胆固醇、甘油三酯没有影响,有降低尿酸的作用,与卡托普利对照组相比,咳嗽发生率低,并能改善肾功能及保护内皮细胞功能。结论:科素亚同卡托普利治疗轻、中度高血压病安全、有效,对血脂、肾功能无影响。科素亚有降低尿酸的作用,咳嗽发生率低

     

    Abstract: Aim: To compare the effects of losartan and captopril on essential hypertension. Methods: Fifty nine patients were treated with losartan, 50 mg~100 mg/d; fifty six patients were treated with captopril 25 mg~75 mg/d for six weeks for comparison. Blood pressure were monitored , blood lipid, urea nitrogen, creatinine, urine acid, blood α 1 MG, and urine α 1 MG,and urine Alb, plasma renin activity (PRA) were examined before and after treatment. Results:There are no difference in the antihypertensive effect between the two drugs.than captopril group. Losartan had no effect on TG and TC, it decrease the level of urine acid; the incidence of cough is lower than that of captoril. Losartan could decrease blood α 1 MG and urine α 1 MG and urine Alb (P <0.001), while plasma renin activity (PRA) was increased( P <0.001). Conclusion:Losartan is effective and safe in treatment of hypertension, and it can decrease the level of urine acid of blood. The incidence of cough is lower than that of captoril.

     

/

返回文章
返回